Search

Author/Creator Rifkind, Irina

1. Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study. Issue 1 (January 2018)

Authors:
Teply, Benjamin A; Wang, Hao; Luber, Brandon; Sullivan, Rana; Rifkind, Irina; Bruns, Ashley; Spitz, Avery; DeCarli, Morgan; Sinibaldi, Victoria; Pratz, Caroline F; Lu, Changxue; Silberstein, John L; Luo, Jun; Schweizer, Michael T; Drake, Charles G; Carducci, Michael A; Paller, Channing J; Antonar...
Journal:
Lancet oncology
Issue:
Volume 19:Issue 1(2018)
Page Start:
76
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Bipolar androgen therapy sensitizes castration-resistant prostate cancer to subsequent androgen receptor ablative therapy. (February 2021)

Authors:
Sena, Laura A.; Wang, Hao; Lim ScM, Su J.; Rifkind, Irina; Ngomba, Nduku; Isaacs, John T.; Luo, Jun; Pratz, Caroline; Sinibaldi, Victoria; Carducci, Michael A.; Paller, Channing J.; Eisenberger, Mario A.; Markowski, Mark C.; Antonarakis, Emmanuel S.; Denmeade, Samuel R.
Journal:
European journal of cancer
Issue:
Volume 144(2021)
Page Start:
302
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search